Update in Epidemiology and Management of Mycoplasma genitalium Infections

Infect Dis Clin North Am. 2023 Jun;37(2):311-333. doi: 10.1016/j.idc.2023.02.009.

Abstract

Mycoplasma genitalium is a frequent cause of urogenital syndromes in men and women and is associated with adverse sequelae in women. M genitalium also infects the rectum, and may cause proctitis, but rarely infects the pharynx. Diagnosis requires nucleic acid amplification testing. Antibiotic resistance is widespread: more than half of infections are resistant to macrolides and fluoroquinolone resistance is increasing. Resistance-guided therapy is recommended for symptomatic patients, involving initial treatment with doxycycline to reduce organism load followed by azithromycin for macrolide-sensitive infections or moxifloxacin for macrolide-resistant infections. Neither screening nor tests of cure are recommended in asymptomatic persons.

Keywords: Antimicrobial resistance; Mycoplasma genitalium; Pelvic inflammatory disease; Urethritis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Macrolides / therapeutic use
  • Male
  • Mycoplasma Infections* / diagnosis
  • Mycoplasma Infections* / drug therapy
  • Mycoplasma Infections* / epidemiology
  • Mycoplasma genitalium* / genetics

Substances

  • Anti-Bacterial Agents
  • Macrolides